Overview
Status
Active
Registry date
2017-10-20
Registered address
ul. Mariana Zdziechowskiego 11/4, 02-659 Warszawa, Poland
Electronic delivery address
AE:PL-52165-25536-TREDE-28
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 13.46mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 683.72kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 12.65mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 3.85mMedianUSD 539.29kAverageUSD 10.66m
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-02-21. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,557$1,557 | Marszałek Województwa Mazowieckiego | |
| Mar 15, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,526$1,526 | Marszałek Województwa Mazowieckiego | |
| Mar 15, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $956$956 | Marszałek Województwa Mazowieckiego |
Tenders
No recorded participation in tenders.
Partners
| Partners | Partner role |
|---|---|
Allpharm Sp. z o.o. | General partner |
Perla Fundacja Rodzinna | General partner |
Manner of representation
Each partner authorized to represent the company has the right to represent the company independently.
Beneficial owners
| Person | Rights | |
|---|---|---|
Tomasz Szlaga (46) | Fundator wspólnika komplementariusza-50%udziałów allpharm sp. z o.o. będącej komplementariuszem spółki zgłaszanej i fundator komandytariusza; Fundator wspólnika ts7 fundacja rodzinna - wspólnik spółki komandytowej -komandytariusz, wielkość udziału 2500 tyś zł | |
Martyna Magdalena Tymińska (42) | Fundator wspólnika komplementariusza-50%udziałów allpharm sp. z o.o. będącej komplementariuszem spółki zgłaszanej i fundator komandytariusza; Fundator wspólnika perla fundacja rodzinna - wspólnik spółki komandytowej -komandytariusz, wielkość udziału 2500 tyś zł |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it | ||
| Medikon Polskasp. z o.o. | $2,666,944.24 | medikon.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-10-20 | Address change (Ul. Domaniewska 17/19/133, 02-672, Warszawa → Ul. Mariana Zdziechowskiego 11/4, 02-659, Warszawa) | |
| 2021-05-27 | Name change (Sorelle → Allpharm) | |
| 2020-03-06 | Address change (Aleja Lotników Polskich 1, 21-045, Świdnik → Ul. Domaniewska 17/19/133, 02-672, Warszawa) | |
| 2020-03-06 | PKD change (Removed: 20.4, 46.45.Z, 46.7, 47.1, 47.5, 47.75.Z, 47.9, 73; Added: 10, 21, 46.1, 46.46.Z, 49, 77, 82) | |
| 2017-10-20 | Entered in the register |
FAQ
The main business activity of Allpharm focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 20, 2017.
The headquarters is located at: ul. Mariana Zdziechowskiego 11, 02-659 Warszawa.
The share capital of the company is PLN 2,000 (approx. $540).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $13,461,628, representing an increase of 300.1% compared to 2024.
Yes, the company recorded a net profit of $683,719 in 2025.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $10,464,723 in 2025, representing 83% of all operating expenses.
Last updated: 2026-03-28
